JFNCX Mutual Fund
JFNCX Mutual Fund
JFNCX Mutual Fund
Janus Henderson Global Life Sciences Fund Class C
JFNCX Mutual Fund Overview
JFNCX Mutual Fund (Janus Henderson Global Life Sciences Fund Class C) is managed by Janus Henderson Investors with $163.5M in net assets. JFNCX expense ratio is 1.79%, holding 104 positions across sectors including Health Care, Financials. Inception date: 2009-07-06.
JFNCX performance shows a YTD return of 6.88%. The 1-year return is 26.55% and the 5-year return is 7.55%.
JFNCX top holdings include Eli Lilly & Co. (8.8%), Johnson & Johnson - Common (7.3%), AstraZeneca PLC (4.6%), Abbvie Inc. (4.0%), Unitedhealth Group Incorporated (3.1%). Go to all JFNCX holdings, JFNCX sectors, or JFNCX dividends.
JFNCX can be compared against other funds. Use JFNCX overlap to find shared positions, or JFNCX vs another fund for a side-by-side view. JFNCX alternatives are available via the screener, along with tax-loss harvesting opportunities.